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CORRESPONDENCEComment on: ‘Effects of Statin Therapy on Abdominal
Aortic Aneurysm Growth: A Meta-analysis and Meta-
regression of Observational Comparative Studies’
Dear Editor,
We read the meta-analysis by Takagi et al.1 with interest.
Unfortunately, the conclusion that statins reduce AAA
expansion is still not justiﬁed by the data.
The problem, as with our analysis widely quoted in the
paper,2 is that the study quality was poor with small patient
numbers in individual studies. Study results were open to
confounding from multiple comorbidities and polypharmacy
in AAA patient groups. Heterogeneity in the authors’ anal-
ysis was highly signiﬁcant (adjusted from P < 0.0001 to
P ¼ 0.005), with a signiﬁcant variation between expansion
rate results suggesting bias. Adjusting confounded or biased
data and performing meta-regression simply produce
further inaccurate results without correcting the underlying
problem. Meta-analysis is only as good as the trial data
entered.3
For these reasons we based our conclusion on sensi-
tivity analysis rather than the meta-analysis of all trials
which found in favour of the statin group.2 Adding the
‘high quality’ trial (Karrowni 2011) published since our
analysis pushes our high quality sensitivity analysis result
into signiﬁcance (SMD 0.25, P ¼ 0.04, Heterogeneity
P < 0.0001) but still gave a non signiﬁcant result from
large volume (>200 patients total) sensitivity analysis
(SMD 0.20, P ¼ 0.07, Heterogeneity P ¼ 0.006), high-
lighting how brittle meta-analysis really is when using
small individual datasets.
A more deﬁnitive attempt to answer this question can
only be made by adjusted re-analysis of pooled raw data
from these studies or a high quality RCT.
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Abdominal Aortic Aneurysm Growth: A Meta-analysis and
Meta-regression of Observational Comparative Studies’
Dear Editor,
We would like to greatly acknowledge the comment by
Twine and Williams on our recently published meta-anal-
ysis.1 In a more recent (after our performing the meta-
analysis1) meta-analysis by the RESCAN collaborators2 of
individual data collated from people under follow-up for
a small (3.0e5.4 cm in diameter) abdominal aortic aneurysm
(AAA), the pooled meta-analysis estimate (4621 patients
from 6 studies) was no longer statistically signiﬁcant for
statins/lipid-lowering drugs (effect estimate [mm/
year], 0.205; standard error, 0.132; P ¼ 0.121) after
adjustment for potential confounding. The most recently,
we3 combined adjusted data for growth rates from high-
quality observational comparative studies identiﬁed by
comprehensive search with those from the individual patient
data meta-analysis by the RESCAN collaborators.2 Pooled
analysis of 13 studies (our identifying 7 studies plus the 6
studies included in the meta-analysis by the RESCAN
collaborators2) demonstrated a statistically signiﬁcant
0.63 mm/year reduction in AAA growth rates with statin
therapy in the random-effects model (95% conﬁdence
interval [CI],0.98 to0.29 mm/year; P for effect¼ 0.0003;
P for heterogeneity < 0.0001). Signiﬁcant statistical
between-study heterogeneity of the study-speciﬁc estimates
may be due to the result by Karrowni et al.4 demonstrating
a probably excess beneﬁt of statin therapy (mean difference
[MD] of growth rates, 3.40 mm/year; 95% CI, 4.63
to 2.17 mm/year). Even though the result by Karrowni
et al.4 was eliminated in sensitivity analyses excluding indi-
vidual studies one at a time, combining the remaining 12
studies (there was minimal between-study heterogeneity
[P ¼ 0.05]) generated an attenuated but still statistically
signiﬁcant result favoring statin therapy (random-effects
MD,e0.42mm/year; 95% CI,e0.66 to0.18mm/year; P for
effect ¼ 0.0007).3 Thus, the evidence of the beneﬁt of statin
therapy for AAA growth is likely compelling and robust.
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j.ejvs.2012.09.024Comment on: ‘Factors Inﬂuencing Wound Healing of
Critical Ischaemic Foot after Bypass Surgery: Is the
Angiosome Important in Selecting Bypass Target Artery?’
Dr. Azuma and his colleagues’ paper categorized the
revascularization of an angiosome as direct or indirect. This
fails to recognize the 3 dimensional anatomy of angiosomes
that includes arterialearterial connections in the foot and
ankle between the arteries feeding the angiosomes. By
failing to recognize the critical role those connections play
in revascularization, the paper cannot accurately judge the
quality of revascularization of a given angiosome.
In counter-distinction,Varela’s paper1 recognizes that fact by
describing 3 types of revascularization of a given angiosome:
direct, indirect through arterialearterial connections and indi-
rect. They found no signiﬁcant difference in healing and limb
salvage rates between thedirectly revascularized group and the
indirectly revascularized via arterialearterial connection(s)
group. On the other hand, there was a signiﬁcant difference
between both groups when compared to the indirectly re-
vascularized group without arterialearterial connections.
I recommend adopting the Varela’s categorization of revas-
cularization whenever using the angiosome concept to more
accurately evaluate the quality of revascularization, limb salvage
rates andwoundhealing outcomes.Theﬁrstwould be thedirect
revascularization (DR) of the artery feeding a given angiosome.
The second would be the indirect revascularization (IRc) of the
artery feeding a given angiosome via arterialearterial connec-
tions. The third would be indirect revascularization (IR) where
the artery feeding the angiosome remains occluded. In this
instance, healing will depend on whether the “choke” vessels2
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Wound Healing of Critical Ischaemic Foot after Bypass
Surgery: Is the Angiosome Important in Selecting Bypass
Target Artery?’
Dear Editor,
As the author of the letter mentioned, the arterial
connection between angiosomes is crucial to determine the
efﬁcacy of angiosome-indirect revascularisation. However, it
was not easy to classify IRc (indirect revascularisation with
arterialearterial connection) and IR (indirect revascularisa-
tion without arterialearterial connection) because of the
following reasons. (1) Preoperative arterial images such as
DSA from the femoral artery, sometimes failed to show
a detailed arteriogram in a severely ischaemic foot because
a sufﬁcient amount of contrast agent could not reach the
foot. (2) Angiography after the establishment of a bypass
could reveal the precise image of the foot. However,
differentiating between IRc and IR was still difﬁcult, because
connecting arteries were also involved in arterial disease to
various degrees or the connection was composed of very
ﬁne arterioles, and it was difﬁcult to determine whether the
network could contribute blood supply to the neighbouring
angiosome. (3) Because the angiosome concept had not
been popularised at the time of our retrospective study, the
detailed three-dimensional completion angiographies were
not available in many cases. (4) Angiography itself has
certain limitations and cannot demonstrate the functional
or haemodynamic role of the connecting circulation
between angiosomes. As we mentioned in our manuscript,
indocyanine green dye is utilised to intraoperatively stain
the “living angiosome” in some cases to ensure that the
angiosome-indirect ﬂow through the bypass graft can
contribute to feeding neighbour angiosomes.
